INBX logo

Inhibrx Biosciences, Inc. (INBX) Net Income

Annual Net Income:

$1.69B+$1.93B(+803.96%)
December 31, 2024

Summary

  • As of today, INBX annual net profit is $1.69 billion, with the most recent change of +$1.93 billion (+803.96%) on December 31, 2024.
  • During the last 3 years, INBX annual net income has risen by +$1.77 billion (+2163.85%).
  • INBX annual net income is now at all-time high.

Performance

INBX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

Quarterly Net Income:

-$35.26M-$6.60M(-23.04%)
September 30, 2025

Summary

  • As of today, INBX quarterly net profit is -$35.26 million, with the most recent change of -$6.60 million (-23.04%) on September 30, 2025.
  • Over the past year, INBX quarterly net income has increased by +$8.61 million (+19.62%).
  • INBX quarterly net income is now -101.90% below its all-time high of $1.86 billion, reached on June 30, 2024.

Performance

INBX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

TTM Net Income:

-$155.09M+$8.61M(+5.26%)
September 30, 2025

Summary

  • As of today, INBX TTM net profit is -$155.09 million, with the most recent change of +$8.61 million (+5.26%) on September 30, 2025.
  • Over the past year, INBX TTM net income has dropped by -$1.89 billion (-108.94%).
  • INBX TTM net income is now -108.72% below its all-time high of $1.78 billion, reached on June 30, 2024.

Performance

INBX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

INBX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+804.0%+19.6%-108.9%
3Y3 Years+2163.8%+0.2%-23.6%
5Y5 Years+3383.2%-72.0%-107.4%

INBX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+804.0%-101.9%+55.2%-108.7%+9.9%
5Y5-Yearat high+804.0%-101.9%+55.2%-108.7%+9.9%
All-TimeAll-Timeat high+804.0%-101.9%+55.2%-108.7%+9.9%

INBX Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$35.26M(-23.0%)
-$155.09M(+5.3%)
Jun 2025
-
-$28.65M(+33.8%)
-$163.69M(-109.5%)
Mar 2025
-
-$43.31M(+9.5%)
$1.72B(+2.1%)
Dec 2024
$1.69B(+804.0%)
-$47.87M(-9.1%)
$1.69B(-2.8%)
Sep 2024
-
-$43.86M(-102.4%)
$1.74B(-2.5%)
Jun 2024
-
$1.86B(+2460.6%)
$1.78B(+1514.8%)
Mar 2024
-
-$78.71M(-67.3%)
-$125.76M(+27.0%)
Dec 2023
-$239.73M(-65.1%)
-
-
Jun 2023
-
-$47.05M(+3.8%)
-$172.21M(-5.7%)
Mar 2023
-
-$48.92M(-19.6%)
-$162.89M(-12.2%)
Dec 2022
-$145.23M(-77.6%)
-$40.91M(-15.8%)
-$145.23M(-15.7%)
Sep 2022
-
-$35.33M(+6.4%)
-$125.50M(-13.3%)
Jun 2022
-
-$37.73M(-20.7%)
-$110.75M(-18.2%)
Mar 2022
-
-$31.25M(-47.5%)
-$93.73M(-14.6%)
Dec 2021
-$81.77M
-$21.19M(-3.0%)
-$81.77M(-4.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$20.58M(+0.6%)
-$78.23M(-0.1%)
Jun 2021
-
-$20.71M(-7.4%)
-$78.14M(-3.8%)
Mar 2021
-
-$19.29M(-9.3%)
-$75.32M(+1.1%)
Dec 2020
-$76.12M(-48.1%)
-$17.65M(+13.9%)
-$76.12M(-1.8%)
Sep 2020
-
-$20.50M(-14.6%)
-$74.78M(-0.4%)
Jun 2020
-
-$17.89M(+11.0%)
-$74.45M(-10.1%)
Mar 2020
-
-$20.09M(-23.2%)
-$67.65M(-31.6%)
Dec 2019
-$51.40M(-64.9%)
-$16.30M(+19.1%)
-$51.40M(-46.5%)
Sep 2019
-
-$20.16M(-81.9%)
-$35.09M(-135.0%)
Jun 2019
-
-$11.09M(-188.1%)
-$14.93M(-35.7%)
Mar 2019
-
-$3.85M(+46.2%)
-$11.00M(+33.4%)
Dec 2018
-$31.16M(-60.3%)
-
-
Jun 2018
-
-$7.16M(+23.5%)
-$16.51M(-76.5%)
Mar 2018
-
-$9.36M
-$9.36M
Dec 2017
-$19.44M
-
-

FAQ

  • What is Inhibrx Biosciences, Inc. annual net profit?
  • What is the all-time high annual net income for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. annual net income year-on-year change?
  • What is Inhibrx Biosciences, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. quarterly net income year-on-year change?
  • What is Inhibrx Biosciences, Inc. TTM net profit?
  • What is the all-time high TTM net income for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. TTM net income year-on-year change?

What is Inhibrx Biosciences, Inc. annual net profit?

The current annual net income of INBX is $1.69B

What is the all-time high annual net income for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high annual net profit is $1.69B

What is Inhibrx Biosciences, Inc. annual net income year-on-year change?

Over the past year, INBX annual net profit has changed by +$1.93B (+803.96%)

What is Inhibrx Biosciences, Inc. quarterly net profit?

The current quarterly net income of INBX is -$35.26M

What is the all-time high quarterly net income for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high quarterly net profit is $1.86B

What is Inhibrx Biosciences, Inc. quarterly net income year-on-year change?

Over the past year, INBX quarterly net profit has changed by +$8.61M (+19.62%)

What is Inhibrx Biosciences, Inc. TTM net profit?

The current TTM net income of INBX is -$155.09M

What is the all-time high TTM net income for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high TTM net profit is $1.78B

What is Inhibrx Biosciences, Inc. TTM net income year-on-year change?

Over the past year, INBX TTM net profit has changed by -$1.89B (-108.94%)
On this page